Breast Cancer
Showing NaN - NaN of 405
Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus
Recruiting
- Mesothelioma
- +14 more
- NGM707
- NGM707 plus pembrolizumab
-
Los Angeles, California
- +13 more
Aug 16, 2022
Breast Cancer Trial in Boston (Atezolizumab, Stereotactic radiosurgery (SRS))
Active, not recruiting
- Breast Cancer
- Atezolizumab
- Stereotactic radiosurgery (SRS)
-
Boston, MassachusettsDana-Farber Cancer Institute
Aug 15, 2022
Breast Cancer, Lung Cancer, Gastrointestinal Cancer Trial in Boston (Resource Matching, Usual Care)
Recruiting
- Breast Cancer
- +2 more
- Resource Matching
- Usual Care
-
Boston, MassachusettsDana Farber Cancer Institute
Aug 15, 2022
Breast Cancer Trial in United States (Tomosynthesis digital mammography imaging system)
Completed
- Breast Cancer
- Tomosynthesis digital mammography imaging system
-
New Haven, Connecticut
- +4 more
Aug 9, 2022
Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Capecitabine, Lapatinib)
Active, not recruiting
- Breast Cancer
- Trastuzumab deruxtecan
- +3 more
-
Chandler, Arizona
- +226 more
Aug 11, 2022
Non Small Cell Lung Cancer, Breast Cancer Trial in Worldwide (Abemaciclib, Pembrolizumab, Anastrozole)
Active, not recruiting
- Non Small Cell Lung Cancer
- Breast Cancer
- Abemaciclib
- +2 more
-
Fayetteville, Arkansas
- +22 more
Aug 8, 2022
ER+ Breast Cancer, Breast Cancer, Aromatase Inhibitors Trial in Boston (White Wine, Grape Juice)
Not yet recruiting
- ER+ Breast Cancer
- +2 more
- White Wine
- Grape Juice
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Aug 1, 2022
Breast Cancer Trial in United States (bicalutamide, diagnostic laboratory biomarker analysis, immunohistochemistry staining
Breast Cancer, Survivorship, Treatment Compliance Trial in United States (Culturally Aware Adjuvant Endocrine Therapy (AET)
Not yet recruiting
- Breast Cancer
- +4 more
- Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention
-
Boston, Massachusetts
- +3 more
Jul 25, 2022
Breast Cancer Trial in Worldwide (Elacestrant, Standard of Care)
Active, not recruiting
- Breast Cancer
- Elacestrant
- Standard of Care
-
Tucson, Arizona
- +167 more
Jul 19, 2022
Fasting, Breast Cancer, Survivorship Trial in Boston (Fasting)
Completed
- Fasting
- +3 more
- Fasting
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jul 18, 2022
Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan)
Recruiting
- Breast Cancer
- Trastuzumab Deruxtecan
-
San Diego, California
- +90 more
Jul 19, 2022
Ovarian Cancer, Breast Cancer, Lung Cancer Trial in Boston, Omaha, Columbus (Digital Health Coaching Program, Fitbit)
Recruiting
- Ovarian Cancer
- +4 more
- Digital Health Coaching Program
- Fitbit
-
Boston, Massachusetts
- +2 more
Jul 13, 2022
Breast Cancer, Chemo Effect, Exercise Therapy Trial in Boston (High-Intensity Intervals Training, Attention Control)
Recruiting
- Breast Cancer
- +3 more
- High-Intensity Intervals Training
- Attention Control
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 5, 2022
Breast Cancer, HER2-positive Breast Cancer Trial in United States (trastuzumab-emtansine, Trastuzumab SC, Paclitaxel)
Recruiting
- Breast Cancer
- HER2-positive Breast Cancer
- trastuzumab-emtansine
- +2 more
-
Stamford, Connecticut
- +16 more
Jun 20, 2022
Breast Cancer Trial in United States (therapeutic conventional surgery, whole breast irradiation)
Active, not recruiting
- Breast Cancer
- therapeutic conventional surgery
- whole breast irradiation
-
Hot Springs, Arkansas
- +349 more
Jun 16, 2022
Breast Cancer Surgery Pain, Breast Cancer, Stage 0-III Breast Cancer Trial in Boston (Qigong Mind-Body Exercise)
Active, not recruiting
- Breast Cancer Surgery Pain
- +2 more
- Qigong Mind-Body Exercise
-
Boston, MassachusettsDana-Farber Cancer Institute
Jun 15, 2022
Breast Cancer Trial in United States (Lapatinib, Letrozole, Trastuzumab)
Breast Cancer, Triple Negative Breast Cancer, Residual Cancer Trial in United States (Atezolizumab, Sacituzumab govitecan)
Recruiting
- Breast Cancer
- +3 more
- Atezolizumab
- Sacituzumab govitecan
-
San Francisco, California
- +8 more
May 25, 2022
Elevate! : An Elderly Breast Cancer Cohort Study
Recruiting
- Breast Cancer
- Observational cohort
-
Bangor, Maine
- +3 more
May 24, 2022